Volume 176 Number 1 JANUARY 2017 REVIEWS R1–R14 MANAGEMENT OF ENDOCRINE DISEASE: The effect of vitamin D supplementation on glycaemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis Yvonne H M Krul-Poel, Marieke M ter Wee, Paul Lips and Suat Simsek R15–R20 MANAGEMENT OF ENDOCRINE DISEASE: Hypothyroidism-associated hyponatremia: mechanisms, implications and treatment G Liamis, T D Filippatos, A Liontos and M S Elisaf R21–R38 MANAGEMENT OF ENDOCRINE DISEASE: Isolated maternal hypothyroxinemia during pregnancy: knowns and unknowns Chrysoula Dosiou and Marco Medici R39–R52 MECHANISMS IN ENDOCRINOLOGY: Kidney involvement in patients with primary hyperparathyroidism: an update on clinical and molecular aspects C Verdelli and S Corbetta CLINICAL STUDIES 1–9 Acute cardiovascular events and all-cause mortality in patients with hyperthyroidism:a population-based cohort study Olaf M Dekkers, Erzsébet Horváth-Puhó, Suzanne C Cannegieter, Jan P Vandenbroucke, Henrik Toft Sørensen and Jens Otto L Jørgensen 11–19 Determinants of hypomagnesemia in patients with type 2 diabetes mellitus Steef Kurstjens, Jeroen H F de Baaij, Hacene Bouras, René J M Bindels, Cees J J Tack and Joost G J Hoenderop 21–30 Marrow adipose tissue spectrum in obesity and type 2 diabetes mellitus Iana M de Araújo, Carlos E G Salmon, Andressa K Nahas, Marcello H Nogueira- Barbosa, Jorge Elias Jr and Francisco J A de Paula 31–39 Mortality in patients with diabetes mellitus and Addison’s disease: a nationwide, matched, observational cohort study Dimitrios Chantzichristos, Anders Persson, Björn Eliasson, Mervete Miftaraj, Stefan Franzén, Ragnhildur Bergthorsdottir, Soffia Gudbjörnsdottir Ann-Marie Svensson and Gudmundur Johannsson 41–48 Incidence of Cushing’s syndrome in patients with significant hypercortisoluria Dania Hirsch, Gloria Tsvetov, Yossi Manisterski, Nirit Aviran-Barak, Varda Nadler, Sandra Alboim and Vered Kopel 49–55 TERT promoter mutations: a genetic signature of benign and malignant thyroid tumours occurring in the context of tinea capitis irradiation Paula Boaventura, Rui Batista, Ana Pestana, Marta Reis, Adélia Mendes, Catarina Eloy, Manuel Sobrinho-Simões and Paula Soares 57–66 Elevated TSH in adults treated for hypothyroidism is associated with increased mortality Amit Akirov, Hannah Gimbel, Alon Grossman, Tzipora Shochat and Ilan Shimon 67–75 Life expectancy in patients with pituitary adenoma receiving growth hormone replacement Daniel S Olsson, Penelope Trimpou, Tobias Hallén, Ing-Liss Bryngelsson, Eva Andersson, Thomas Skoglund, Bengt- Åke Bengtsson, Gudmundur Johannsson, and Anna G Nilsson 77–86 Heart rate acceleration with GLP-1 receptor agonists in type 2 diabetes patients: an acute and 12-week randomised, double-blind, placebo- controlled trial Mark M Smits, Lennart Tonneijck, Marcel H A Muskiet, Trynke Hoekstra, Mark H H Kramer, Michaela Diamant and Daniël H van Raalte CONTENTS CONTINUED ON THE INSIDE BACK COVER
2
Embed
Volume 176 Number 1 JANUARY 2017 - eje-online.org · Volume 176 Number 1 JANUARY 2017 Volume 176 Number 1 ... Daniël H van Raalte ... Larissa Guebelin, Christian Degen, Beat Mueller
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Vo
lume 176
Num
ber 1
January 2017P
ages P
1–P17, R
247–R295, 499–660, X
3
Volume 176 Number 1JANUARY 2017
Volume 176 Number 1
JANUARY 2017
REVIEWSR1–R14 MANAGEMENT OF ENDOCRINE DISEASE:
The effect of vitamin D supplementation on glycaemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
Yvonne H M Krul-Poel, Marieke M ter Wee, Paul Lips and Suat Simsek
R15–R20 MANAGEMENT OF ENDOCRINE DISEASE: Hypothyroidism-associated hyponatremia: mechanisms, implications and treatment
G Liamis, T D Filippatos, A Liontos and M S Elisaf
R21–R38 MANAGEMENT OF ENDOCRINE DISEASE: Isolated maternal hypothyroxinemia during pregnancy: knowns and unknowns
Chrysoula Dosiou and Marco Medici
R39–R52 MECHANISMS IN ENDOCRINOLOGY: Kidney involvement in patients with primary hyperparathyroidism: an update on clinical and molecular aspects
C Verdelli and S Corbetta
CLINICAL STUDIES1–9 Acute cardiovascular events and all-cause
mortality in patients with hyperthyroidism:a population-based cohort study
Olaf M Dekkers, Erzsébet Horváth-Puhó, Suzanne C Cannegieter, Jan P Vandenbroucke, Henrik Toft Sørensen and Jens Otto L Jørgensen
11–19 Determinants of hypomagnesemia in patients with type 2 diabetes mellitus
Steef Kurstjens, Jeroen H F de Baaij, Hacene Bouras, René J M Bindels, Cees J J Tack and Joost G J Hoenderop
21–30 Marrow adipose tissue spectrum in obesity and type 2 diabetes mellitus
Iana M de Araújo, Carlos E G Salmon, Andressa K Nahas, Marcello H Nogueira-Barbosa, Jorge Elias Jr and Francisco J A de Paula
31–39 Mortality in patients with diabetes mellitus and Addison’s disease: a nationwide, matched, observational cohort study
Dimitrios Chantzichristos, Anders Persson, Björn Eliasson, Mervete Miftaraj, Stefan Franzén, Ragnhildur Bergthorsdottir, Soffia Gudbjörnsdottir Ann-Marie Svensson and Gudmundur Johannsson
41–48 Incidence of Cushing’s syndrome in patients with significant hypercortisoluria
49–55 TERT promoter mutations: a genetic signature of benign and malignant thyroid tumours occurring in the context of tinea capitis irradiation
Paula Boaventura, Rui Batista, Ana Pestana, Marta Reis, Adélia Mendes, Catarina Eloy, Manuel Sobrinho-Simões and Paula Soares
57–66 Elevated TSH in adults treated for hypothyroidism is associated with increased mortality
Amit Akirov, Hannah Gimbel, Alon Grossman, Tzipora Shochat and Ilan Shimon
67–75 Life expectancy in patients with pituitary adenoma receiving growth hormone replacement
Daniel S Olsson, Penelope Trimpou, Tobias Hallén, Ing-Liss Bryngelsson, Eva Andersson, Thomas Skoglund, Bengt-Åke Bengtsson, Gudmundur Johannsson, and Anna G Nilsson
77–86 Heart rate acceleration with GLP-1 receptor agonists in type 2 diabetes patients: an acute and 12-week randomised, double-blind, placebo-controlled trial
Mark M Smits, Lennart Tonneijck, Marcel H A Muskiet, Trynke Hoekstra, Mark H H Kramer, Michaela Diamant and Daniël H van Raalte
CONTENTS CONTINUED ON THE INSIDE BACK COVER
European Journal of Endocrinology (www.eje-online.org; ISSN 0804-4643 (print), ISSN 1479-683X (online)) is published monthly by Bioscientifica Ltd, Euro House, 22 Apex Court, Woodlands, Bradley Stoke, Bristol BS32 4JT, UK (Email: [email protected]). (Registered in England no. 3190519)
FrequencyEuropean Journal of Endocrinology is published monthly online and in print. There are two volumes per year and six issues form a volume.
Abstracting and indexingIndexed/abstracted in: Chemical Abstracts, Current Content/Life Sciences, EMBASE/Excerpta Medica, Index Medicus/MEDLINE, Science Citation Index, Pascal/INIST-CNRS, Science Citation Index Expanded, Scopus, SIIC Salud.
Editorial address and submissionsThe journal accepts online submissions only. Guidelines for this can be found via www.eje-online.org. Editorial correspondence should be addressed to Professor J A Romijn, Editor-in-Chief, European Journal of Endocrinology, Email: [email protected]. Papers that exceed a certain length will be liable for page charges; details are given in the instructions to authors which appear online.
Business addressBusiness matters, other than subscriptions and requests for back issues, should be addressed to Bioscientifica Ltd at the address above.
AdvertisementsAdvertising enquiries should be sent to: [email protected]. Copy is required 6 weeks before publication date. Rates are available online.
Subscription rates 2016
INSTITUTIONS $2880/£1551/€2275 (print and online) $2304/£1241/€1820 (online only) plus VAT where applicable
CORPORATE $3744/£2017/€2958 (print and online) $2995/£1613/€2366 (online only) plus VAT where applicable
All orders, accompanied by payment, should be sent direct to their agent for distribution, European Journal of Endocrinology, Turpin Distribution, Pegasus Drive, Stratton Business Park, Biggleswade SG18 8TQ, UK (Tel: +44 (0)1767 604951; Fax: +44 (0) 1767 601640; Email: [email protected]).
Claims and communicationAll communications or claims regarding issues lost or damaged in transit should be addressed to the distributor (see above for address). No claims can be entertained if they are later than 3 months after the date of despatch.
DisclaimerThe papers contained in each issue of the journal have been prepared and written by named authors. Accordingly, neither the European Society of Endocrinology, Bioscientifica Ltd nor their officers, employees or agents are responsible for the accuracy or otherwise of any papers and shall have no liability for any claims, damages or losses however arising from the contents of any papers or any use to which they may be put by any person.
Special regulation for photocopies in the USA: authorization to photocopy items for internal
or personal use, or the internal or personal use of specific clients, is granted by the European Society of Endocrinology for libraries and other users registered with the Copyright Clearance Center Transactional Reporting Service, provided the appropriate fee is paid to Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923, USA, Tel: 978-750-8400; Fax: 978-646-8600; Email: [email protected]. Prior to photocopying items for educational classroom use, please contact Copyright Clearance Center, Inc. at the address shown above. This authorization does not include copying for general distribution, promotion, new works, or resale.
In these cases, specific written permission must be requested from the European Society of Endocrinology at the business address above.
AcknowledgementsTypeset by OKS Prepress Services, Chennai, India. Printed and bound by Henry Ling Ltd, Dorset, UK